Jiangning Yang

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes.

Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes.

Journal: Antioxidants (Basel, Switzerland)

Published: November 21, 2025

microRNA-210 in red blood cells differentially regulates vascular endothelial function between type 1 and type 2 diabetes.

microRNA-210 in red blood cells differentially regulates vascular endothelial function between type 1 and type 2 diabetes.

Journal: Physiological reports

Published: November 21, 2025

Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.

Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.

Journal: Diabetes

Published: May 14, 2025

Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction.

Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction.

Journal: American journal of physiology. Heart and circulatory physiology

Published: October 11, 2024

Red blood cells: a new target to prevent cardiovascular disease?

Red blood cells: a new target to prevent cardiovascular disease?

Journal: European heart journal

Published: September 11, 2024

Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase.

Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase.

Journal: Clinical science (London, England : 1979)

Published: March 12, 2024

Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes.

Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes.

Journal: The Journal of clinical investigation

Published: March 08, 2024

miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.

miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.

Journal: British journal of pharmacology

Published: February 06, 2024

Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP.

Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP.

Journal: The Journal of clinical investigation

Published: December 01, 2022

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia.

The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia.

Journal: Journal of internal medicine

Published: November 03, 2022

Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes.

Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes.

Journal: JACC. Basic to translational science

Published: July 22, 2022

Erythrocytes Induce Vascular Dysfunction in COVID-19.

Erythrocytes Induce Vascular Dysfunction in COVID-19.

Journal: JACC. Basic to translational science

Published: October 05, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026